Form4insider filings, from the source

SEC Form 4 · accession 0001765581-19-000025

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul Treacy
Officer — SVP, Technical Operations
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 7:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF2Feb 28, 2019A5,000$0.00A22,583D
Ordinary SharesMar 1, 2019S523$139.50D22,060D
Ordinary SharesMar 1, 2019S351$139.50D21,709D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F4$140.03Feb 28, 2019A12,500A—Feb 27, 2029Ordinary Shares12,50012,500D

Explanation of responses